Practical considerations of β-blockade in the management of the post–myocardial infarction patient
- 30 June 2005
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 149 (6) , 984-993
- https://doi.org/10.1016/j.ahj.2005.02.008
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation, 2004
- AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 updateJournal of the American College of Cardiology, 2001
- Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trialThe Lancet, 2001
- 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and RecommendationsCirculation, 1999
- beta Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 1999
- The Lopressor Intervention Trial: Multicentre study of metoprolol in survivors of acute myocardial infarctionEuropean Heart Journal, 1987
- Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trialEuropean Heart Journal, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981